Durvalumab cost-effectiveness in limited-stage small cell lung cancer failed to meet US value thresholds despite longer ...
Researchers conducted a systematic review of studies assessing the cost-effectiveness or cost-utility of adjuvant immunotherapy for treating various types of cancer.
Sotorasib is more cost-effective in treating patients with KRAS G12C non–small cell lung cancer (NSCLC) compared with adagrasib in second- and subsequent-line treatment, accordi ...
Characterizing Opioid Prescribing Trends of Medical Oncologists From 2013 to 2019: Analysis From the Centers for Medicare & Medicaid Services Medicare Part D Prescribers Database This work supported ...
Introduction Many neonatal deaths are avoidable using existing low-cost evidence-based interventions. This study evaluated ...
Launch prices often differ from actual prices due to discounts, complicating comparisons with value-based prices from cost-effectiveness analyses. Conventional cost-effectiveness analyses may overlook ...
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...
A multicomponent exercise program that includes strength, aerobic, agility, and balance training exercises is cost-effective and results in improved cognition among stroke survivors, compared with a ...
In an analysis of adults with class II obesity (BMI 35-39.9), endoscopic sleeve gastroplasty (ESG) added 0.06 more quality-adjusted life-years while costing $33,583 less than semaglutide (Wegovy) over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results